nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—ABCG2—Dactinomycin—muscle cancer	0.12	0.142	CbGbCtD
Buprenorphine—ABCG2—Vincristine—muscle cancer	0.0742	0.0875	CbGbCtD
Buprenorphine—ABCG2—Etoposide—muscle cancer	0.068	0.0802	CbGbCtD
Buprenorphine—CYP1A2—Dacarbazine—muscle cancer	0.0573	0.0676	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0548	0.0646	CbGbCtD
Buprenorphine—CYP3A7—Vincristine—muscle cancer	0.0548	0.0646	CbGbCtD
Buprenorphine—ABCG2—Doxorubicin—muscle cancer	0.0464	0.0547	CbGbCtD
Buprenorphine—ABCG2—Methotrexate—muscle cancer	0.0449	0.053	CbGbCtD
Buprenorphine—ABCB1—Dactinomycin—muscle cancer	0.0434	0.0512	CbGbCtD
Buprenorphine—CYP3A5—Vincristine—muscle cancer	0.0411	0.0485	CbGbCtD
Buprenorphine—CYP3A5—Etoposide—muscle cancer	0.0377	0.0444	CbGbCtD
Buprenorphine—CYP2C8—Etoposide—muscle cancer	0.0362	0.0427	CbGbCtD
Buprenorphine—CYP1A2—Etoposide—muscle cancer	0.028	0.0331	CbGbCtD
Buprenorphine—ABCB1—Vincristine—muscle cancer	0.0268	0.0316	CbGbCtD
Buprenorphine—ABCB1—Etoposide—muscle cancer	0.0245	0.0289	CbGbCtD
Buprenorphine—ABCB1—Doxorubicin—muscle cancer	0.0167	0.0197	CbGbCtD
Buprenorphine—ABCB1—Methotrexate—muscle cancer	0.0162	0.0191	CbGbCtD
Buprenorphine—CYP3A4—Vincristine—muscle cancer	0.016	0.0189	CbGbCtD
Buprenorphine—CYP2D6—Doxorubicin—muscle cancer	0.0158	0.0186	CbGbCtD
Buprenorphine—CYP3A4—Etoposide—muscle cancer	0.0147	0.0173	CbGbCtD
Buprenorphine—CYP3A4—Doxorubicin—muscle cancer	0.01	0.0118	CbGbCtD
Buprenorphine—Menopausal symptoms—Doxorubicin—muscle cancer	0.000378	0.00249	CcSEcCtD
Buprenorphine—Insomnia—Vincristine—muscle cancer	0.000378	0.00248	CcSEcCtD
Buprenorphine—Paraesthesia—Vincristine—muscle cancer	0.000375	0.00247	CcSEcCtD
Buprenorphine—Malaise—Etoposide—muscle cancer	0.000374	0.00246	CcSEcCtD
Buprenorphine—Breast disorder—Methotrexate—muscle cancer	0.000372	0.00245	CcSEcCtD
Buprenorphine—Vertigo—Etoposide—muscle cancer	0.000372	0.00245	CcSEcCtD
Buprenorphine—Abdominal pain—Dactinomycin—muscle cancer	0.000369	0.00243	CcSEcCtD
Buprenorphine—Body temperature increased—Dactinomycin—muscle cancer	0.000369	0.00243	CcSEcCtD
Buprenorphine—Loss of consciousness—Etoposide—muscle cancer	0.000364	0.0024	CcSEcCtD
Buprenorphine—Lethargy—Doxorubicin—muscle cancer	0.000364	0.0024	CcSEcCtD
Buprenorphine—Decreased appetite—Vincristine—muscle cancer	0.000363	0.00239	CcSEcCtD
Buprenorphine—Cough—Etoposide—muscle cancer	0.000362	0.00238	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Vincristine—muscle cancer	0.00036	0.00237	CcSEcCtD
Buprenorphine—Fatigue—Vincristine—muscle cancer	0.00036	0.00237	CcSEcCtD
Buprenorphine—Convulsion—Etoposide—muscle cancer	0.000359	0.00236	CcSEcCtD
Buprenorphine—Hypertension—Etoposide—muscle cancer	0.000358	0.00235	CcSEcCtD
Buprenorphine—Pain—Vincristine—muscle cancer	0.000357	0.00235	CcSEcCtD
Buprenorphine—Constipation—Vincristine—muscle cancer	0.000357	0.00235	CcSEcCtD
Buprenorphine—Pain in extremity—Doxorubicin—muscle cancer	0.000357	0.00235	CcSEcCtD
Buprenorphine—Osteoarthritis—Doxorubicin—muscle cancer	0.000357	0.00235	CcSEcCtD
Buprenorphine—Diplopia—Doxorubicin—muscle cancer	0.000357	0.00235	CcSEcCtD
Buprenorphine—Asthma—Methotrexate—muscle cancer	0.000356	0.00234	CcSEcCtD
Buprenorphine—Chest pain—Etoposide—muscle cancer	0.000353	0.00232	CcSEcCtD
Buprenorphine—Affect lability—Doxorubicin—muscle cancer	0.000351	0.00231	CcSEcCtD
Buprenorphine—Migraine—Doxorubicin—muscle cancer	0.000351	0.00231	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00035	0.00231	CcSEcCtD
Buprenorphine—Discomfort—Etoposide—muscle cancer	0.000349	0.00229	CcSEcCtD
Buprenorphine—Face oedema—Doxorubicin—muscle cancer	0.000345	0.00227	CcSEcCtD
Buprenorphine—Hypersensitivity—Dactinomycin—muscle cancer	0.000344	0.00227	CcSEcCtD
Buprenorphine—Abdominal discomfort—Methotrexate—muscle cancer	0.000342	0.00225	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Vincristine—muscle cancer	0.000341	0.00225	CcSEcCtD
Buprenorphine—Confusional state—Etoposide—muscle cancer	0.000341	0.00224	CcSEcCtD
Buprenorphine—Anaphylactic shock—Etoposide—muscle cancer	0.000338	0.00223	CcSEcCtD
Buprenorphine—Mood swings—Doxorubicin—muscle cancer	0.000338	0.00222	CcSEcCtD
Buprenorphine—Infection—Etoposide—muscle cancer	0.000336	0.00221	CcSEcCtD
Buprenorphine—Asthenia—Dactinomycin—muscle cancer	0.000335	0.00221	CcSEcCtD
Buprenorphine—Dehydration—Doxorubicin—muscle cancer	0.000332	0.00218	CcSEcCtD
Buprenorphine—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000331	0.00218	CcSEcCtD
Buprenorphine—Tachycardia—Etoposide—muscle cancer	0.00033	0.00217	CcSEcCtD
Buprenorphine—Abdominal pain—Vincristine—muscle cancer	0.00033	0.00217	CcSEcCtD
Buprenorphine—Body temperature increased—Vincristine—muscle cancer	0.00033	0.00217	CcSEcCtD
Buprenorphine—Skin disorder—Etoposide—muscle cancer	0.000329	0.00216	CcSEcCtD
Buprenorphine—Dry skin—Doxorubicin—muscle cancer	0.000327	0.00215	CcSEcCtD
Buprenorphine—Hyperhidrosis—Etoposide—muscle cancer	0.000327	0.00215	CcSEcCtD
Buprenorphine—Abdominal pain upper—Doxorubicin—muscle cancer	0.000326	0.00215	CcSEcCtD
Buprenorphine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000326	0.00215	CcSEcCtD
Buprenorphine—Breast disorder—Doxorubicin—muscle cancer	0.000323	0.00212	CcSEcCtD
Buprenorphine—Anorexia—Etoposide—muscle cancer	0.000322	0.00212	CcSEcCtD
Buprenorphine—Diarrhoea—Dactinomycin—muscle cancer	0.00032	0.0021	CcSEcCtD
Buprenorphine—Nasopharyngitis—Doxorubicin—muscle cancer	0.000319	0.0021	CcSEcCtD
Buprenorphine—Infestation—Methotrexate—muscle cancer	0.000318	0.00209	CcSEcCtD
Buprenorphine—Infestation NOS—Methotrexate—muscle cancer	0.000318	0.00209	CcSEcCtD
Buprenorphine—Depression—Methotrexate—muscle cancer	0.000317	0.00208	CcSEcCtD
Buprenorphine—Hypotension—Etoposide—muscle cancer	0.000316	0.00208	CcSEcCtD
Buprenorphine—Muscular weakness—Doxorubicin—muscle cancer	0.000315	0.00207	CcSEcCtD
Buprenorphine—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000315	0.00207	CcSEcCtD
Buprenorphine—Abdominal distension—Doxorubicin—muscle cancer	0.000311	0.00204	CcSEcCtD
Buprenorphine—Conjunctivitis—Methotrexate—muscle cancer	0.000309	0.00203	CcSEcCtD
Buprenorphine—Dysphagia—Doxorubicin—muscle cancer	0.000308	0.00203	CcSEcCtD
Buprenorphine—Asthma—Doxorubicin—muscle cancer	0.000308	0.00203	CcSEcCtD
Buprenorphine—Influenza—Doxorubicin—muscle cancer	0.000308	0.00203	CcSEcCtD
Buprenorphine—Hypersensitivity—Vincristine—muscle cancer	0.000308	0.00202	CcSEcCtD
Buprenorphine—Sweating—Methotrexate—muscle cancer	0.000305	0.002	CcSEcCtD
Buprenorphine—Paraesthesia—Etoposide—muscle cancer	0.000304	0.002	CcSEcCtD
Buprenorphine—Dyspnoea—Etoposide—muscle cancer	0.000302	0.00198	CcSEcCtD
Buprenorphine—Somnolence—Etoposide—muscle cancer	0.000301	0.00198	CcSEcCtD
Buprenorphine—Angina pectoris—Doxorubicin—muscle cancer	0.0003	0.00198	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Methotrexate—muscle cancer	0.0003	0.00198	CcSEcCtD
Buprenorphine—Asthenia—Vincristine—muscle cancer	0.0003	0.00197	CcSEcCtD
Buprenorphine—Vomiting—Dactinomycin—muscle cancer	0.000297	0.00196	CcSEcCtD
Buprenorphine—Bronchitis—Doxorubicin—muscle cancer	0.000297	0.00195	CcSEcCtD
Buprenorphine—Rash—Dactinomycin—muscle cancer	0.000295	0.00194	CcSEcCtD
Buprenorphine—Decreased appetite—Etoposide—muscle cancer	0.000294	0.00193	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000292	0.00192	CcSEcCtD
Buprenorphine—Fatigue—Etoposide—muscle cancer	0.000292	0.00192	CcSEcCtD
Buprenorphine—Constipation—Etoposide—muscle cancer	0.000289	0.0019	CcSEcCtD
Buprenorphine—Pain—Etoposide—muscle cancer	0.000289	0.0019	CcSEcCtD
Buprenorphine—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000287	0.00189	CcSEcCtD
Buprenorphine—Diarrhoea—Vincristine—muscle cancer	0.000286	0.00188	CcSEcCtD
Buprenorphine—Pharyngitis—Methotrexate—muscle cancer	0.000283	0.00186	CcSEcCtD
Buprenorphine—Urinary tract disorder—Methotrexate—muscle cancer	0.000282	0.00185	CcSEcCtD
Buprenorphine—Urethral disorder—Methotrexate—muscle cancer	0.00028	0.00184	CcSEcCtD
Buprenorphine—Weight decreased—Doxorubicin—muscle cancer	0.000279	0.00184	CcSEcCtD
Buprenorphine—Feeling abnormal—Etoposide—muscle cancer	0.000279	0.00183	CcSEcCtD
Buprenorphine—Nausea—Dactinomycin—muscle cancer	0.000278	0.00183	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Etoposide—muscle cancer	0.000277	0.00182	CcSEcCtD
Buprenorphine—Dizziness—Vincristine—muscle cancer	0.000276	0.00182	CcSEcCtD
Buprenorphine—Infestation NOS—Doxorubicin—muscle cancer	0.000275	0.00181	CcSEcCtD
Buprenorphine—Infestation—Doxorubicin—muscle cancer	0.000275	0.00181	CcSEcCtD
Buprenorphine—Visual impairment—Methotrexate—muscle cancer	0.000275	0.00181	CcSEcCtD
Buprenorphine—Urticaria—Etoposide—muscle cancer	0.000269	0.00177	CcSEcCtD
Buprenorphine—Abdominal pain—Etoposide—muscle cancer	0.000267	0.00176	CcSEcCtD
Buprenorphine—Body temperature increased—Etoposide—muscle cancer	0.000267	0.00176	CcSEcCtD
Buprenorphine—Conjunctivitis—Doxorubicin—muscle cancer	0.000267	0.00176	CcSEcCtD
Buprenorphine—Urinary tract infection—Doxorubicin—muscle cancer	0.000267	0.00176	CcSEcCtD
Buprenorphine—Eye disorder—Methotrexate—muscle cancer	0.000266	0.00175	CcSEcCtD
Buprenorphine—Tinnitus—Methotrexate—muscle cancer	0.000266	0.00175	CcSEcCtD
Buprenorphine—Vomiting—Vincristine—muscle cancer	0.000265	0.00175	CcSEcCtD
Buprenorphine—Cardiac disorder—Methotrexate—muscle cancer	0.000265	0.00174	CcSEcCtD
Buprenorphine—Sweating—Doxorubicin—muscle cancer	0.000264	0.00174	CcSEcCtD
Buprenorphine—Rash—Vincristine—muscle cancer	0.000263	0.00173	CcSEcCtD
Buprenorphine—Dermatitis—Vincristine—muscle cancer	0.000263	0.00173	CcSEcCtD
Buprenorphine—Headache—Vincristine—muscle cancer	0.000262	0.00172	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00026	0.00171	CcSEcCtD
Buprenorphine—Angiopathy—Methotrexate—muscle cancer	0.000259	0.0017	CcSEcCtD
Buprenorphine—Sinusitis—Doxorubicin—muscle cancer	0.000258	0.0017	CcSEcCtD
Buprenorphine—Immune system disorder—Methotrexate—muscle cancer	0.000258	0.00169	CcSEcCtD
Buprenorphine—Mediastinal disorder—Methotrexate—muscle cancer	0.000257	0.00169	CcSEcCtD
Buprenorphine—Chills—Methotrexate—muscle cancer	0.000256	0.00168	CcSEcCtD
Buprenorphine—Bradycardia—Doxorubicin—muscle cancer	0.000251	0.00165	CcSEcCtD
Buprenorphine—Mental disorder—Methotrexate—muscle cancer	0.00025	0.00164	CcSEcCtD
Buprenorphine—Hypersensitivity—Etoposide—muscle cancer	0.000249	0.00164	CcSEcCtD
Buprenorphine—Erythema—Methotrexate—muscle cancer	0.000248	0.00163	CcSEcCtD
Buprenorphine—Malnutrition—Methotrexate—muscle cancer	0.000248	0.00163	CcSEcCtD
Buprenorphine—Nausea—Vincristine—muscle cancer	0.000248	0.00163	CcSEcCtD
Buprenorphine—Rhinitis—Doxorubicin—muscle cancer	0.000248	0.00163	CcSEcCtD
Buprenorphine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000246	0.00162	CcSEcCtD
Buprenorphine—Pharyngitis—Doxorubicin—muscle cancer	0.000245	0.00161	CcSEcCtD
Buprenorphine—Urinary tract disorder—Doxorubicin—muscle cancer	0.000244	0.0016	CcSEcCtD
Buprenorphine—Oedema peripheral—Doxorubicin—muscle cancer	0.000243	0.0016	CcSEcCtD
Buprenorphine—Dysgeusia—Methotrexate—muscle cancer	0.000243	0.0016	CcSEcCtD
Buprenorphine—Asthenia—Etoposide—muscle cancer	0.000243	0.0016	CcSEcCtD
Buprenorphine—Connective tissue disorder—Doxorubicin—muscle cancer	0.000243	0.0016	CcSEcCtD
Buprenorphine—Urethral disorder—Doxorubicin—muscle cancer	0.000242	0.00159	CcSEcCtD
Buprenorphine—Back pain—Methotrexate—muscle cancer	0.00024	0.00158	CcSEcCtD
Buprenorphine—Pruritus—Etoposide—muscle cancer	0.000239	0.00157	CcSEcCtD
Buprenorphine—Visual impairment—Doxorubicin—muscle cancer	0.000238	0.00157	CcSEcCtD
Buprenorphine—Vision blurred—Methotrexate—muscle cancer	0.000234	0.00154	CcSEcCtD
Buprenorphine—Diarrhoea—Etoposide—muscle cancer	0.000231	0.00152	CcSEcCtD
Buprenorphine—Eye disorder—Doxorubicin—muscle cancer	0.000231	0.00152	CcSEcCtD
Buprenorphine—Ill-defined disorder—Methotrexate—muscle cancer	0.00023	0.00152	CcSEcCtD
Buprenorphine—Tinnitus—Doxorubicin—muscle cancer	0.00023	0.00151	CcSEcCtD
Buprenorphine—Flushing—Doxorubicin—muscle cancer	0.000229	0.00151	CcSEcCtD
Buprenorphine—Cardiac disorder—Doxorubicin—muscle cancer	0.000229	0.00151	CcSEcCtD
Buprenorphine—Angiopathy—Doxorubicin—muscle cancer	0.000224	0.00147	CcSEcCtD
Buprenorphine—Malaise—Methotrexate—muscle cancer	0.000224	0.00147	CcSEcCtD
Buprenorphine—Dizziness—Etoposide—muscle cancer	0.000224	0.00147	CcSEcCtD
Buprenorphine—Immune system disorder—Doxorubicin—muscle cancer	0.000223	0.00147	CcSEcCtD
Buprenorphine—Vertigo—Methotrexate—muscle cancer	0.000223	0.00147	CcSEcCtD
Buprenorphine—Mediastinal disorder—Doxorubicin—muscle cancer	0.000223	0.00146	CcSEcCtD
Buprenorphine—Chills—Doxorubicin—muscle cancer	0.000222	0.00146	CcSEcCtD
Buprenorphine—Cough—Methotrexate—muscle cancer	0.000217	0.00143	CcSEcCtD
Buprenorphine—Mental disorder—Doxorubicin—muscle cancer	0.000216	0.00142	CcSEcCtD
Buprenorphine—Convulsion—Methotrexate—muscle cancer	0.000215	0.00142	CcSEcCtD
Buprenorphine—Vomiting—Etoposide—muscle cancer	0.000215	0.00142	CcSEcCtD
Buprenorphine—Erythema—Doxorubicin—muscle cancer	0.000215	0.00141	CcSEcCtD
Buprenorphine—Malnutrition—Doxorubicin—muscle cancer	0.000215	0.00141	CcSEcCtD
Buprenorphine—Rash—Etoposide—muscle cancer	0.000213	0.0014	CcSEcCtD
Buprenorphine—Dermatitis—Etoposide—muscle cancer	0.000213	0.0014	CcSEcCtD
Buprenorphine—Headache—Etoposide—muscle cancer	0.000212	0.00139	CcSEcCtD
Buprenorphine—Flatulence—Doxorubicin—muscle cancer	0.000212	0.00139	CcSEcCtD
Buprenorphine—Chest pain—Methotrexate—muscle cancer	0.000211	0.00139	CcSEcCtD
Buprenorphine—Arthralgia—Methotrexate—muscle cancer	0.000211	0.00139	CcSEcCtD
Buprenorphine—Myalgia—Methotrexate—muscle cancer	0.000211	0.00139	CcSEcCtD
Buprenorphine—Tension—Doxorubicin—muscle cancer	0.000211	0.00139	CcSEcCtD
Buprenorphine—Dysgeusia—Doxorubicin—muscle cancer	0.00021	0.00139	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00021	0.00138	CcSEcCtD
Buprenorphine—Discomfort—Methotrexate—muscle cancer	0.000209	0.00137	CcSEcCtD
Buprenorphine—Nervousness—Doxorubicin—muscle cancer	0.000209	0.00137	CcSEcCtD
Buprenorphine—Back pain—Doxorubicin—muscle cancer	0.000208	0.00137	CcSEcCtD
Buprenorphine—Muscle spasms—Doxorubicin—muscle cancer	0.000207	0.00136	CcSEcCtD
Buprenorphine—Confusional state—Methotrexate—muscle cancer	0.000204	0.00134	CcSEcCtD
Buprenorphine—Anaphylactic shock—Methotrexate—muscle cancer	0.000203	0.00133	CcSEcCtD
Buprenorphine—Vision blurred—Doxorubicin—muscle cancer	0.000203	0.00133	CcSEcCtD
Buprenorphine—Infection—Methotrexate—muscle cancer	0.000201	0.00132	CcSEcCtD
Buprenorphine—Nausea—Etoposide—muscle cancer	0.000201	0.00132	CcSEcCtD
Buprenorphine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000199	0.00131	CcSEcCtD
Buprenorphine—Nervous system disorder—Methotrexate—muscle cancer	0.000199	0.00131	CcSEcCtD
Buprenorphine—Agitation—Doxorubicin—muscle cancer	0.000198	0.0013	CcSEcCtD
Buprenorphine—Skin disorder—Methotrexate—muscle cancer	0.000197	0.00129	CcSEcCtD
Buprenorphine—Hyperhidrosis—Methotrexate—muscle cancer	0.000196	0.00129	CcSEcCtD
Buprenorphine—Malaise—Doxorubicin—muscle cancer	0.000194	0.00128	CcSEcCtD
Buprenorphine—Vertigo—Doxorubicin—muscle cancer	0.000193	0.00127	CcSEcCtD
Buprenorphine—Anorexia—Methotrexate—muscle cancer	0.000193	0.00127	CcSEcCtD
Buprenorphine—Syncope—Doxorubicin—muscle cancer	0.000193	0.00127	CcSEcCtD
Buprenorphine—Palpitations—Doxorubicin—muscle cancer	0.00019	0.00125	CcSEcCtD
Buprenorphine—Hypotension—Methotrexate—muscle cancer	0.000189	0.00125	CcSEcCtD
Buprenorphine—Loss of consciousness—Doxorubicin—muscle cancer	0.000189	0.00124	CcSEcCtD
Buprenorphine—Cough—Doxorubicin—muscle cancer	0.000188	0.00123	CcSEcCtD
Buprenorphine—Convulsion—Doxorubicin—muscle cancer	0.000186	0.00123	CcSEcCtD
Buprenorphine—Hypertension—Doxorubicin—muscle cancer	0.000186	0.00122	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000185	0.00121	CcSEcCtD
Buprenorphine—Insomnia—Methotrexate—muscle cancer	0.000183	0.00121	CcSEcCtD
Buprenorphine—Arthralgia—Doxorubicin—muscle cancer	0.000183	0.0012	CcSEcCtD
Buprenorphine—Chest pain—Doxorubicin—muscle cancer	0.000183	0.0012	CcSEcCtD
Buprenorphine—Myalgia—Doxorubicin—muscle cancer	0.000183	0.0012	CcSEcCtD
Buprenorphine—Anxiety—Doxorubicin—muscle cancer	0.000182	0.0012	CcSEcCtD
Buprenorphine—Paraesthesia—Methotrexate—muscle cancer	0.000182	0.0012	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000182	0.0012	CcSEcCtD
Buprenorphine—Discomfort—Doxorubicin—muscle cancer	0.000181	0.00119	CcSEcCtD
Buprenorphine—Dyspnoea—Methotrexate—muscle cancer	0.000181	0.00119	CcSEcCtD
Buprenorphine—Somnolence—Methotrexate—muscle cancer	0.00018	0.00119	CcSEcCtD
Buprenorphine—Dry mouth—Doxorubicin—muscle cancer	0.000179	0.00118	CcSEcCtD
Buprenorphine—Dyspepsia—Methotrexate—muscle cancer	0.000178	0.00117	CcSEcCtD
Buprenorphine—Confusional state—Doxorubicin—muscle cancer	0.000177	0.00116	CcSEcCtD
Buprenorphine—Decreased appetite—Methotrexate—muscle cancer	0.000176	0.00116	CcSEcCtD
Buprenorphine—Oedema—Doxorubicin—muscle cancer	0.000175	0.00115	CcSEcCtD
Buprenorphine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000175	0.00115	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000175	0.00115	CcSEcCtD
Buprenorphine—Fatigue—Methotrexate—muscle cancer	0.000175	0.00115	CcSEcCtD
Buprenorphine—Infection—Doxorubicin—muscle cancer	0.000174	0.00115	CcSEcCtD
Buprenorphine—Pain—Methotrexate—muscle cancer	0.000173	0.00114	CcSEcCtD
Buprenorphine—Shock—Doxorubicin—muscle cancer	0.000173	0.00114	CcSEcCtD
Buprenorphine—Nervous system disorder—Doxorubicin—muscle cancer	0.000172	0.00113	CcSEcCtD
Buprenorphine—Tachycardia—Doxorubicin—muscle cancer	0.000171	0.00113	CcSEcCtD
Buprenorphine—Skin disorder—Doxorubicin—muscle cancer	0.00017	0.00112	CcSEcCtD
Buprenorphine—Hyperhidrosis—Doxorubicin—muscle cancer	0.00017	0.00112	CcSEcCtD
Buprenorphine—Anorexia—Doxorubicin—muscle cancer	0.000167	0.0011	CcSEcCtD
Buprenorphine—Feeling abnormal—Methotrexate—muscle cancer	0.000167	0.0011	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000166	0.00109	CcSEcCtD
Buprenorphine—Hypotension—Doxorubicin—muscle cancer	0.000164	0.00108	CcSEcCtD
Buprenorphine—Urticaria—Methotrexate—muscle cancer	0.000161	0.00106	CcSEcCtD
Buprenorphine—Body temperature increased—Methotrexate—muscle cancer	0.00016	0.00105	CcSEcCtD
Buprenorphine—Abdominal pain—Methotrexate—muscle cancer	0.00016	0.00105	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00016	0.00105	CcSEcCtD
Buprenorphine—Insomnia—Doxorubicin—muscle cancer	0.000159	0.00104	CcSEcCtD
Buprenorphine—Paraesthesia—Doxorubicin—muscle cancer	0.000158	0.00104	CcSEcCtD
Buprenorphine—Dyspnoea—Doxorubicin—muscle cancer	0.000156	0.00103	CcSEcCtD
Buprenorphine—Somnolence—Doxorubicin—muscle cancer	0.000156	0.00103	CcSEcCtD
Buprenorphine—Dyspepsia—Doxorubicin—muscle cancer	0.000154	0.00102	CcSEcCtD
Buprenorphine—Decreased appetite—Doxorubicin—muscle cancer	0.000152	0.001	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000151	0.000997	CcSEcCtD
Buprenorphine—Fatigue—Doxorubicin—muscle cancer	0.000151	0.000995	CcSEcCtD
Buprenorphine—Pain—Doxorubicin—muscle cancer	0.00015	0.000987	CcSEcCtD
Buprenorphine—Constipation—Doxorubicin—muscle cancer	0.00015	0.000987	CcSEcCtD
Buprenorphine—Hypersensitivity—Methotrexate—muscle cancer	0.000149	0.000982	CcSEcCtD
Buprenorphine—Asthenia—Methotrexate—muscle cancer	0.000145	0.000956	CcSEcCtD
Buprenorphine—Feeling abnormal—Doxorubicin—muscle cancer	0.000145	0.000951	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000143	0.000944	CcSEcCtD
Buprenorphine—Pruritus—Methotrexate—muscle cancer	0.000143	0.000943	CcSEcCtD
Buprenorphine—Urticaria—Doxorubicin—muscle cancer	0.000139	0.000917	CcSEcCtD
Buprenorphine—Abdominal pain—Doxorubicin—muscle cancer	0.000139	0.000913	CcSEcCtD
Buprenorphine—Body temperature increased—Doxorubicin—muscle cancer	0.000139	0.000913	CcSEcCtD
Buprenorphine—Diarrhoea—Methotrexate—muscle cancer	0.000139	0.000912	CcSEcCtD
Buprenorphine—Dizziness—Methotrexate—muscle cancer	0.000134	0.000882	CcSEcCtD
Buprenorphine—Hypersensitivity—Doxorubicin—muscle cancer	0.000129	0.00085	CcSEcCtD
Buprenorphine—Vomiting—Methotrexate—muscle cancer	0.000129	0.000848	CcSEcCtD
Buprenorphine—Rash—Methotrexate—muscle cancer	0.000128	0.000841	CcSEcCtD
Buprenorphine—Dermatitis—Methotrexate—muscle cancer	0.000128	0.00084	CcSEcCtD
Buprenorphine—Headache—Methotrexate—muscle cancer	0.000127	0.000835	CcSEcCtD
Buprenorphine—Asthenia—Doxorubicin—muscle cancer	0.000126	0.000828	CcSEcCtD
Buprenorphine—Pruritus—Doxorubicin—muscle cancer	0.000124	0.000817	CcSEcCtD
Buprenorphine—Nausea—Methotrexate—muscle cancer	0.00012	0.000792	CcSEcCtD
Buprenorphine—Diarrhoea—Doxorubicin—muscle cancer	0.00012	0.00079	CcSEcCtD
Buprenorphine—Dizziness—Doxorubicin—muscle cancer	0.000116	0.000763	CcSEcCtD
Buprenorphine—Vomiting—Doxorubicin—muscle cancer	0.000112	0.000734	CcSEcCtD
Buprenorphine—Rash—Doxorubicin—muscle cancer	0.000111	0.000728	CcSEcCtD
Buprenorphine—Dermatitis—Doxorubicin—muscle cancer	0.000111	0.000727	CcSEcCtD
Buprenorphine—Headache—Doxorubicin—muscle cancer	0.00011	0.000723	CcSEcCtD
Buprenorphine—Nausea—Doxorubicin—muscle cancer	0.000104	0.000686	CcSEcCtD
